Personalized Therapy in the Era of Precision Medicine: Guidance on Histology-Agnostic Therapies for the Community Multidisciplinary Oncology Team

Experts discuss histology-agnostic therapies for solid tumors, including key efficacy and safety data and guidance on appropriate molecular testing and adverse event management with an on-demand webcast and downloadable slideset from a live workshop series.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by educational grants from Bayer HealthCare Pharmaceuticals Inc., Elevation Oncology, Merck Sharp & Dohme Corp., and Merus NV.

Bayer HealthCare Pharmaceuticals Inc.

Elevation Oncology

Merck Sharp & Dohme Corp.

Merus NV